These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32534029)

  • 1. Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products.
    Zhang S; Xiao H; Goren M; Burakov D; Chen G; Li N; Tustian A; Adams B; Mattila J; Bak H
    J Pharm Sci; 2020 Sep; 109(9):2710-2718. PubMed ID: 32534029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations.
    Hall T; Sandefur SL; Frye CC; Tuley TL; Huang L
    J Pharm Sci; 2016 May; 105(5):1633-1642. PubMed ID: 27056628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the specific causes of polysorbate 20 degradation in monoclonal antibody formulations containing multiple lipases.
    Zhang S; Riccardi C; Kamen D; Reilly J; Mattila J; Bak H; Xiao H; Li N
    Pharm Res; 2022 Jan; 39(1):75-87. PubMed ID: 34981317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Polysorbate 80 Degradation by Liver Carboxylesterase in a Monoclonal Antibody Formulated Drug Substance at Early Stage Development.
    Zhang S; Xiao H; Molden R; Qiu H; Li N
    J Pharm Sci; 2020 Nov; 109(11):3300-3307. PubMed ID: 32721471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations.
    Zhang S; Xiao H; Li N
    J Pharm Sci; 2021 Dec; 110(12):3866-3873. PubMed ID: 34487744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms.
    Hecht ES; Mehta S; Wecksler AT; Aguilar B; Swanson N; Phung W; Dubey Kelsoe A; Benner WH; Tesar D; Kelley RF; Sandoval W; Sreedhara A
    MAbs; 2022; 14(1):2135183. PubMed ID: 36284469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling Active Enzymes for Polysorbate Degradation in Biotherapeutics by Activity-Based Protein Profiling.
    Li X; Chandra D; Letarte S; Adam GC; Welch J; Yang RS; Rivera S; Bodea S; Dow A; Chi A; Strulson CA; Richardson DD
    Anal Chem; 2021 Jun; 93(23):8161-8169. PubMed ID: 34032423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Recombinantly-Expressed Hydrolytic Enzymes from Chinese Hamster Ovary Cells: Identification of Host Cell Proteins that Degrade Polysorbate.
    Kovner D; Yuk IH; Shen A; Li H; Graf T; Gupta S; Liu W; Tomlinson A
    J Pharm Sci; 2023 May; 112(5):1351-1363. PubMed ID: 36646283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual Host Cell Protein Promotes Polysorbate 20 Degradation in a Sulfatase Drug Product Leading to Free Fatty Acid Particles.
    Dixit N; Salamat-Miller N; Salinas PA; Taylor KD; Basu SK
    J Pharm Sci; 2016 May; 105(5):1657-1666. PubMed ID: 27032893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-Based Protein Profiling Probe for the Detection of Enzymes Catalyzing Polysorbate Degradation.
    Liu GY; Nie S; Zheng X; Li N
    Anal Chem; 2022 Jun; 94(24):8625-8632. PubMed ID: 35679579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Protein Particle Formation in IgG1 mAbs Formulated with PS20 Vs. PS80 When Subjected to Interfacial Dilatational Stress.
    Vaclaw C; Merritt K; Griffin VP; Whitaker N; Gokhale M; Volkin DB; Ogunyankin MO; Dhar P
    AAPS PharmSciTech; 2023 Apr; 24(5):104. PubMed ID: 37081185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.
    Tomlinson A; Zarraga IE; Demeule B
    Mol Pharm; 2020 Jul; 17(7):2345-2353. PubMed ID: 32442382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations.
    Maier M; Weiß L; Zeh N; Schmieder-Todtenhaupt V; Dehghani A; Felix MN; Heinzelmann D; Lindner B; Schmidt M; Studts J; Schulz P; Reisinger B; Otte K; Franzreb M; Lakatos D; Fischer S
    MAbs; 2024; 16(1):2375798. PubMed ID: 38984665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Super Refined™ Polysorbate 20 With Respect to Polysorbate Degradation, Particle Formation and Protein Stability.
    Doshi N; Fish R; Padilla K; Yadav S
    J Pharm Sci; 2020 Oct; 109(10):2986-2995. PubMed ID: 32679214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysorbates versus Hydroxypropyl Beta-Cyclodextrin (HPβCD): Comparative Study on Excipient Stability and Stabilization Benefits on Monoclonal Antibodies.
    Zhang H; Hong S; Tan SSK; Peng T; Goh LYH; Lam KH; Chow KT; Gokhale R
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations.
    Gregoritza K; Theodorou C; Heitz M; Graf T; Germershaus O; Gregoritza M
    Eur J Pharm Biopharm; 2024 Jan; 194():74-84. PubMed ID: 38042510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations.
    Zegota MM; Schuster G; De Pra M; Müllner T; Menzen T; Steiner F; Hawe A
    J Chromatogr A; 2024 Apr; 1720():464777. PubMed ID: 38432108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations.
    Chiu J; Valente KN; Levy NE; Min L; Lenhoff AM; Lee KH
    Biotechnol Bioeng; 2017 May; 114(5):1006-1015. PubMed ID: 27943242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the polysorbate degradation fingerprints and kinetics of lipases - how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions.
    Glücklich N; Carle S; Buske J; Mäder K; Garidel P
    Eur J Pharm Sci; 2021 Nov; 166():105980. PubMed ID: 34419573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method.
    Zhang S; Riccardi C; Kamen D; Xiao H; Li N
    Anal Biochem; 2022 Jan; 637():114472. PubMed ID: 34801481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.